News on Osteosarcoma_Bone_Cancer from BioPortfolio.com http://www.BioPortfolio.com Consolidated Osteosarcoma_Bone_Cancer news from BioPortfolio.com Wed, 10 Feb 2010 08:45:58 GMT en New treatment for bone cancer patients launchedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030088&HITNO=0&MSIZE=42&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Osteosarcoma_Bone_Cancer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030088&THISHREF=http://c.moreover.com/click/here.pl%3fz2533433324%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030088&HITNO=0&MSIZE=42&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Osteosarcoma_Bone_Cancer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030088&THISHREF=http://c.moreover.com/click/here.pl%3fz2533433324%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPJ Online: Takeda launches osteosarcoma medicine Mepact in EUhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028620&HITNO=1&MSIZE=42&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Osteosarcoma_Bone_Cancer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028620&THISHREF=http://c.moreover.com/click/here.pl%3fz2532788228%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028620&HITNO=1&MSIZE=42&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Osteosarcoma_Bone_Cancer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028620&THISHREF=http://c.moreover.com/click/here.pl%3fz2532788228%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: Angell Animal Medical Center in Boston Adds Oncologisthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4020152&HITNO=2&MSIZE=42&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Osteosarcoma_Bone_Cancer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4020152&THISHREF=http://c.moreover.com/click/here.pl%3fz2526621731%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4020152&HITNO=2&MSIZE=42&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Osteosarcoma_Bone_Cancer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4020152&THISHREF=http://c.moreover.com/click/here.pl%3fz2526621731%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comVeterinary Practice News: First Treatment To Improve Survival In 20 Years Now Available For Patients With Osteosarcoma (Bone Cancer)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4007457&HITNO=3&MSIZE=42&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Osteosarcoma_Bone_Cancer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4007457&THISHREF=http://c.moreover.com/click/here.pl%3fz2521141699%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4007457&HITNO=3&MSIZE=42&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Osteosarcoma_Bone_Cancer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4007457&THISHREF=http://c.moreover.com/click/here.pl%3fz2521141699%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: First Treatment to Improve Survival in 20 Yearshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3995554&HITNO=4&MSIZE=42&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Osteosarcoma_Bone_Cancer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3995554&THISHREF=http://c.moreover.com/click/here.pl%3fz2515731023%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3995554&HITNO=4&MSIZE=42&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Osteosarcoma_Bone_Cancer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3995554&THISHREF=http://c.moreover.com/click/here.pl%3fz2515731023%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmiWeb: TopoTarget Earns $30M Up Front in Deal with Spectrum for Late-Stage Anticancer Agenthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4000618&HITNO=5&MSIZE=42&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Osteosarcoma_Bone_Cancer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4000618&THISHREF=http://c.moreover.com/click/here.pl%3fz2518107603%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4000618&HITNO=5&MSIZE=42&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Osteosarcoma_Bone_Cancer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4000618&THISHREF=http://c.moreover.com/click/here.pl%3fz2518107603%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: First Treatment to Improve Survival in 20 Years Now Available for Patients with Osteosarcoma (Bone Cancer)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3990400&HITNO=6&MSIZE=42&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Osteosarcoma_Bone_Cancer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3990400&THISHREF=http://c.moreover.com/click/here.pl%3fz2513300784%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3990400&HITNO=6&MSIZE=42&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Osteosarcoma_Bone_Cancer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3990400&THISHREF=http://c.moreover.com/click/here.pl%3fz2513300784%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comAsahi.com: Spectrum Pharmaceuticals Reports Results of FDA Meeting on Fusile...http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3974108&HITNO=7&MSIZE=42&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Osteosarcoma_Bone_Cancer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3974108&THISHREF=http://c.moreover.com/click/here.pl%3fz2503294406%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3974108&HITNO=7&MSIZE=42&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Osteosarcoma_Bone_Cancer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3974108&THISHREF=http://c.moreover.com/click/here.pl%3fz2503294406%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comZibb: FDA wants more information on expanded use of Spectrum's Fusilevhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3967383&HITNO=8&MSIZE=42&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Osteosarcoma_Bone_Cancer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3967383&THISHREF=http://c.moreover.com/click/here.pl%3fz2499655054%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3967383&HITNO=8&MSIZE=42&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Osteosarcoma_Bone_Cancer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3967383&THISHREF=http://c.moreover.com/click/here.pl%3fz2499655054%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSmartBrief: Spectrum Pharmaceuticals Announces Results Of FDA Meeting Regarding FUSILEV(R) SNDA Under Review For Advancedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3968469&HITNO=9&MSIZE=42&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Osteosarcoma_Bone_Cancer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3968469&THISHREF=http://c.moreover.com/click/here.pl%3fz2500388152%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3968469&HITNO=9&MSIZE=42&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Osteosarcoma_Bone_Cancer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3968469&THISHREF=http://c.moreover.com/click/here.pl%3fz2500388152%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedical News Today: Spectrum Pharmaceuticals Announces Results of FDA Meeting Regarding FUSILEV(R) sNDA under Review for Advancedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3961640&HITNO=10&MSIZE=42&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Osteosarcoma_Bone_Cancer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3961640&THISHREF=http://c.moreover.com/click/here.pl%3fz2496867557%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3961640&HITNO=10&MSIZE=42&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Osteosarcoma_Bone_Cancer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3961640&THISHREF=http://c.moreover.com/click/here.pl%3fz2496867557%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comHealthcare Sales & Marketing Network: UPDATE 1-Spectrum says FDA asks for more data on cancer drughttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3956519&HITNO=11&MSIZE=42&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Osteosarcoma_Bone_Cancer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3956519&THISHREF=http://c.moreover.com/click/here.pl%3fz2494584446%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3956519&HITNO=11&MSIZE=42&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Osteosarcoma_Bone_Cancer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3956519&THISHREF=http://c.moreover.com/click/here.pl%3fz2494584446%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comInteractive Investor: UPDATE 1-Spectrum says FDA asks for more data on cancer drughttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3956562&HITNO=12&MSIZE=42&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Osteosarcoma_Bone_Cancer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3956562&THISHREF=http://c.moreover.com/click/here.pl%3fz2494619230%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3956562&HITNO=12&MSIZE=42&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Osteosarcoma_Bone_Cancer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3956562&THISHREF=http://c.moreover.com/click/here.pl%3fz2494619230%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comReuters: Spectrum Pharmaceuticals, Inc. (SPPI) Says FDA Asks for More Data on Cancer Drughttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3957458&HITNO=13&MSIZE=42&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Osteosarcoma_Bone_Cancer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3957458&THISHREF=http://c.moreover.com/click/here.pl%3fz2494960797%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3957458&HITNO=13&MSIZE=42&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Osteosarcoma_Bone_Cancer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3957458&THISHREF=http://c.moreover.com/click/here.pl%3fz2494960797%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBioSpace: Spectrum Pharmaceuticals Announces Results of FDA Meeting Regarding FUSILEV sNDA under Review for Advanced Metastatic Colorectal Cancerhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3956312&HITNO=14&MSIZE=42&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Osteosarcoma_Bone_Cancer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3956312&THISHREF=http://c.moreover.com/click/here.pl%3fz2494491392%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3956312&HITNO=14&MSIZE=42&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Osteosarcoma_Bone_Cancer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3956312&THISHREF=http://c.moreover.com/click/here.pl%3fz2494491392%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFinanzNachrichten.de: